Holger Jahn - Concepedia

Author

Holger Jahn

Also Known As

Florian Gärtner, H JAHN, H Jahn, H. JAHN, H. Jahn, Hans-Jrgen Huppertz, Holger JAHN, Holger Jahn, Jahn, Holger, Johannes Prudlo

245

Publications

8.7K

Citations

H-Index

123

Concepts

All Affiliations

Universität Hamburg University Medical Center Hamburg-Eppendorf Friedrich-Alexander-Universität Erlangen-Nürnberg Ludwig-Maximilians-Universität München Technical University of Munich

About

Holger Jahn is an author at Universität Hamburg specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	46	3.4K
2	Social Sciences	13	14	1.3K
3	Health Sciences	10	11	584
4	Arts	2	2	59
5	Engineering	2	2	241

Holger Jahn

103

Publications

8.2K

Citations

H-Index

Page 1

	Year	Citations
Memory loss in Alzheimer's disease Holger Jahn Dialogues in Clinical Neuroscience	2013	624
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease David M. Good, Petra Zürbig, Àngel Argilés, Molecular & Cellular Proteomics	2010	531
Disruption of ClC-3, a Chloride Channel Expressed on Synaptic Vesicles, Leads to a Loss of the Hippocampus Sandra M. Stobrawa, Tilman Breiderhoff, Shigeo Takamori, Neuron Synaptic PlasticityCellular NeurobiologyMolecular PhysiologyNeurophysiologySynaptic Vesicles	2001	506
Comparing and Combining Naltrexone and Acamprosate in Relapse Prevention of Alcoholism Falk Kiefer, Holger Jahn, Timo Tarnaske, Archives of General Psychiatry	2003	399
Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin Hannelore Ehrenreich, Dunja Hinze‐Selch, Sabina Stawicki, Molecular Psychiatry NeuropsychologyBrain FunctionChronic Schizophrenic PatientsNeuropsychiatrySocial Sciences	2006	259
Amyloid β peptide ratio 42/40 but not Aβ42 correlates with phospho‐Tau in patients with low‐ and high‐CSF Aβ40 load Jens Wiltfang, Hermann Esselmann, Mirko Bibl, Journal of Neurochemistry Amyloid βNeurochemical BiomarkersAlzheimer's DiseaseDegenerative PathologyProtein Misfolding	2006	253
MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease Johannes Denk, Kai Boelmans, Christine S. Siegismund, PLoS ONE EngineeringUnique MirnasNeurochemical BiomarkersMirbase-21 DatabaseS Disease	2015	222
Metyrapone as Additive Treatment in Major Depression Holger Jahn, Mildred Schick, Falk Kiefer, Archives of General Psychiatry	2004	183
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease Michael Wagner, Sebastián Wolf, Friedel M. Reischies, Neurology	2012	175
Investigations on CXCL13 in Anti–<i>N</i>-Methyl-<scp>D</scp>-Aspartate Receptor Encephalitis Frank Leypoldt, Romana Höftberger, Maarten J. Titulaer, JAMA Neurology	2014	170

Page 1